MICROCIN C: BIOSYNTHESIS, MODE OF ACTION, AND POTENTIAL AS A LEAD IN ANTIBIOTICS DEVELOPMENT

被引：7

作者：

Vondenhoff, Gaston H. M. ^{[1
]}

Van Aerschot, Arthur ^{[1
]}

机构：

[1] Katholieke Univ Leuven, Med Chem Lab, Rega Inst Med Res, B-3000 Louvain, Belgium

来源：

NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | 2011年 / 30卷 / 7-9期

关键词：

Microcin C; aminoacyl tRNA synthetase inhibitors; antibiotics; aminoacyl sulfamoyl adenosine; TRANSFER-RNA SYNTHETASE; ESCHERICHIA-COLI; ANTIMICROBIAL AGENTS; ADENYLATE ANALOGS; MATURATION; RESISTANCE; INHIBITORS; TRANSPORTER; PEPTIDASE; MECHANISM;

D O I：

10.1080/15257770.2011.583972

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The natural compound Microcin C (McC) is a Trojan home inhibitor of aspartyl tRNA synthetases endowed with strong antibacterial properties, in which a heptapeptide moiety is responsible for active transport of the inhibitory metabolite part into the bacterial cell. The intracellularly formed aspartyl AMP analogue carries a chemically more stable phosphoramidate linkage, in comparison to the labile aspartyl-adenylate, and in addition is esterified with a 3-aminopropyl moiety. Therefore, this compound can target aspartyl-tRNA synthetase. The biochemical production and secretion of McC, and the possibilities to develop new classes of antibiotics using the McC Trojan horse concept in combination with sulfamoylated adenosine analogues will be discussed briefly.

引用

页码：465 / 474

页数：10

共 50 条

[21] Lead Toxicity in Cereals: Mechanistic Insight Into Toxicity, Mode of Action, and Management
Aslam, Muhammad
Aslam, Ayesha
Sheraz, Muhammad
Ali, Basharat
Ulhassan, Zaid
Najeeb, Ullah
Zhou, Weijun
Gill, Rafaqat Ali
FRONTIERS IN PLANT SCIENCE, 2021, 11
[22] Mode of action and biosynthesis of the azabicycle-containing natural products azinomycin and ficellomycin
Foulke-Abel, Jennifer
Agbo, Hillary
Zhang, Huitu
Mori, Shogo
Watanabe, Coran M. H.
NATURAL PRODUCT REPORTS, 2011, 28 (04) : 693 - 704
[23] Recent Advances in Mode of Action and Biosynthesis Studies of the Clinically Used Antibiotic Fidaxomicin
Dorst, Andrea
Jung, Erik
Gademann, Karl
CHIMIA, 2020, 74 (04) : 270 - 273
[24] Cystobactamid 507: Concise Synthesis, Mode of Action, and Optimization toward More Potent Antibiotics
Elgaher, Walid A. M.
Hamed, Mostafa M.
Baumann, Sascha
Herrmann, Jennifer
Siebenbuerger, Lorenz
Krull, Jana
Cirnski, Katarina
Kirschning, Andreas
Broenstrup, Mark
Mueller, Rolf
Hartmann, Rolf W.
CHEMISTRY-A EUROPEAN JOURNAL, 2020, 26 (32) : 7219 - 7225
[25] Biocontrol potential and mode of action of entomopathogenic bacteria Xenorhabdus budapestensis C72 against Bipolaris maydis
Li, Bo
Kong, Lingxiao
Qiu, Dewen
Francis, Frederic
Wang, Shuangchao
BIOLOGICAL CONTROL, 2021, 158
[26] Synthesis, bioactivity and mode of action of 5A5B6C tricyclic spirolactones as novel antiviral lead compounds
Zhu, Yu-Jie
Wu, Qi-Fan
Fan, Zhi-Jin
Huo, Jing-Qian
Zhang, Jin-Lin
Zhao, Bin
Lai, Chen
Qian, Xiao-Lin
Ma, De-Jun
Wang, Da-Wei
PEST MANAGEMENT SCIENCE, 2019, 75 (01) : 292 - 301
[27] Mode of action, new targets and potential biomarkers in modern immunotherapy
Bedke, J.
Stuehler, V.
Todenhoefer, T.
Stenzl, A.
UROLOGE, 2018, 57 (11): : 1301 - 1308
[28] The Mode of Action of Endosidin20 Differs from That of Other Cellulose Biosynthesis Inhibitors
Huang, Lei
Zhang, Chunhua
PLANT AND CELL PHYSIOLOGY, 2020, 61 (12) : 2139 - 2152
[29] CLAVULANIC ACID AND CEPHAMICIN C: A PERSPECTIVE OF THE BIOSYNTHESIS, ISOLATION AND ACTION MECHANISM
de Oliveira, Jaine H. H. Luiz
Granato, Ana Claudia
Hirata, Daniela B.
Hokka, Carlos O.
Barboza, Marlei
Trsic, Milan
QUIMICA NOVA, 2009, 32 (08): : 2142 - 2150
[30] Inhibition of Escherichia coli ribosome subunit dissociation by chloramphenicol and Blasticidin: a new mode of action of the antibiotics
Pathak, B. K.
Mondal, S.
Barat, C.
LETTERS IN APPLIED MICROBIOLOGY, 2017, 64 (01) : 79 - 85

← 1 2 3 4 5 →